# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014820
Filing Date
2022-08-04
Accepted
2022-08-04 16:44:37
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rptx-20220630.htm iXBRL | 10-Q | 2981964
2 | EX-5.1 | rptx-ex5_1.htm | EX-5.1 | 19698
3 | EX-10.1 | rptx-ex10_1.htm | EX-10.1 | 1902234
4 | EX-10.2 | rptx-ex10_2.htm | EX-10.2 | 407963
5 | EX-31.1 | rptx-ex31_1.htm | EX-31.1 | 20207
6 | EX-31.2 | rptx-ex31_2.htm | EX-31.2 | 20455
7 | EX-32.1 | rptx-ex32_1.htm | EX-32.1 | 10284
8 | EX-32.2 | rptx-ex32_2.htm | EX-32.2 | 10428
9 | GRAPHIC | img46999202_0.jpg | GRAPHIC | 3037
| Complete submission text file | 0000950170-22-014820.txt |  | 10719753

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | rptx-20220630_lab.xml | EX-101.LAB | 338970
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | rptx-20220630_def.xml | EX-101.DEF | 114088
12 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rptx-20220630.xsd | EX-101.SCH | 38251
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | rptx-20220630_cal.xml | EX-101.CAL | 39766
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | rptx-20220630_pre.xml | EX-101.PRE | 247923
57 | EXTRACTED XBRL INSTANCE DOCUMENT | rptx-20220630_htm.xml | XML | 1434291

Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 221137366
SIC: 2834 Pharmaceutical Preparations